Glucagon-like peptide-1 (GLP-1) analogs also known as incretin mimetics are class of drugs indicated for type-2 diabetes mellitus to lower the blood sugar level Mr. Shah Coherent Market Insights Pvt.

A study has found no evidence that glucagon-like peptide 1 receptor agonist (GLP1-RA) use is associated with an increased ...

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

For patients with diabetes undergoing a surgical procedure, an active perioperative glucagon-like peptide-1 receptor agonist ...

The series A fundraising is the biggest ever for a European biotech firm, according to the data provider PitchBook.

Investors, startups and insurers are promoting individual coverage health reimbursement arrangements, known as ICHRAs, even ...

BMI falls short as a way to measure obesity. Doctors need to also determine whether body fat harms a person's health.

The most negatively impacted sectors are frozen, refrigerated, general food and beverages. Circana found GLP-1 users’ monthly ...

For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

With the holidays past and the new year arrived, we look ahead — to losing weight. For some that resolve theoretically ...

More than half of respondents to a survey were unaware that bariatric surgery may improve some women’s chances of getting ...